Predictive Factors for Initial MMSE Score and Rapid Decline in Alzheimer's Disease Patients

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorCentre Hospitalier de Gonesse

About this trial

This study looks at people with Alzheimer's disease to find out which factors are linked to their initial score on the Mini-Mental State Examination (MMSE) and which factors may predict a fast decline in their score over 12 months. Researchers will review medical records from patients seen at the Memory Clinic of Gonesse Hospital and analyze information such as age, education, medical history, nutrition, mood, and caregiver burden. The goal is to better understand what influences early cognitive performance and how quickly it changes, to help improve patient care and planning.

Eligibility criteria

Qualifiers

Confirmed diagnosis of Alzheimer's disease according to NIAA 2018 or IWG 2021 criteria

At least two MMSE evaluations spaced 12 months apart

Follow-up at the Memory Clinic of CH Gonesse

Disqualifiers

Presence of other neurodegenerative diseases (e.g., Frontotemporal Dementia, Multiple System Atrophy, Vascular Dementia, LATE)

Patient has moved out of the study area (outside the CH Gonesse territory)

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators